Compile Data Set for Download or QSAR
maximum 50k data
Found 435 Enz. Inhib. hit(s) with all data for entry = 9265
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454042(US10730863, Example 503)
Affinity DataEC50:  31nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454043(US10730863, Example 504)
Affinity DataEC50:  33nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454041(US10730863, Example 502)
Affinity DataEC50:  1.50E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454044(US10730863, Example 505)
Affinity DataEC50:  88nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454045(US10730863, Example 506)
Affinity DataEC50:  6nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454046(US10730863, Example 507)
Affinity DataEC50:  20nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454047(US10730863, Example 508)
Affinity DataEC50:  100nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454048(US10730863, Example 509)
Affinity DataEC50:  40nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454049(US10730863, Example 510)
Affinity DataEC50:  410nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454050(US10730863, Example 511)
Affinity DataEC50:  2.90E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454051(US10730863, Example 512)
Affinity DataEC50:  43nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454052(US10730863, Example 513)
Affinity DataEC50:  960nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454053(US10730863, Example 514)
Affinity DataEC50:  1.70E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454054(US10730863, Example 524)
Affinity DataEC50:  1.50E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454055(US10730863, Example 525)
Affinity DataEC50:  167nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454056(US10730863, Example 526)
Affinity DataEC50:  296nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454057(US10730863, Example 527)
Affinity DataEC50:  86nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454058(US10730863, Example 528)
Affinity DataEC50:  16nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454059(US10730863, Example 529)
Affinity DataEC50:  9nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454060(US10730863, Example 530)
Affinity DataEC50:  219nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454061(US10730863, Example 531)
Affinity DataEC50:  138nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454062(US10730863, Example 532)
Affinity DataEC50:  148nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454063(US10730863, Example 533)
Affinity DataEC50:  1.91E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454064(US10730863, Example 534)
Affinity DataEC50:  248nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454065(US10730863, Example 535)
Affinity DataEC50:  50nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454066(US10730863, Example 536)
Affinity DataEC50:  55nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454067(US10730863, Example 537)
Affinity DataEC50:  79nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454068(US10730863, Example 538)
Affinity DataEC50:  90nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454069(1-cyclopropyl-3-hydroxy-1H-pyrazole-5-carboxylate ...)
Affinity DataEC50:  25nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454070(US10730863, Example 540)
Affinity DataEC50:  345nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454071(US10730863, Example 541)
Affinity DataEC50:  59nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454072(US10730863, Example 542)
Affinity DataEC50:  4.88E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454073(US10730863, Example 543)
Affinity DataEC50:  469nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454074(US10730863, Example 544)
Affinity DataEC50:  118nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454075(US10730863, Example 545)
Affinity DataEC50:  5nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454076(US10730863, Example 546)
Affinity DataEC50:  7nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454077(US10730863, Example 547)
Affinity DataEC50:  251nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454078(US10730863, Example 548)
Affinity DataEC50:  13nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454079(US10730863, Example 549)
Affinity DataEC50:  126nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454080(US10730863, Example 550)
Affinity DataEC50:  186nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454081(US10730863, Example 551)
Affinity DataEC50:  406nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454082(US10730863, Example 552)
Affinity DataEC50:  100nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454083(US10730863, Example 553)
Affinity DataEC50:  12nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454084(US10730863, Example 554)
Affinity DataEC50:  3.16E+3nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454085(US10730863, Example 555)
Affinity DataEC50:  87nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454086(US10730863, Example 556)
Affinity DataEC50:  30nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454087(US10730863, Example 557)
Affinity DataEC50:  188nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454088(US10730863, Example 558)
Affinity DataEC50:  20nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454089(US10730863, Example 559)
Affinity DataEC50:  20nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM454090(US10730863, Example 560)
Affinity DataEC50:  286nMAssay Description:A Gal4-hFXR fusion construct reporter system was used as the primary assay to characterize compound activity. A construct including 5 copies of the G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 435 total ) | Next | Last >>
Jump to: